VRBCF (Virbac) Current Deferred Taxes Liabilities: $0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRBCF Virbac SA VRBCF
80 GF Score
Price $383.25
GF Value $352.03
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Virbac Current Deferred Taxes Liabilities?

Virbac VRBCF 80 Current Deferred Taxes Liabilities is $0 Mil as of Dec. 2025. GuruFocus rates VRBCF with a GF Score™ of 80/100 and a GF Value™ of $352.03 (Fairly Valued). The stock has 2 warning signs investors should review.

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Virbac's current deferred tax liabilities for the quarter that ended in Dec. 2025 was $0 Mil.

Virbac Current Deferred Taxes Liabilities Related Terms

Virbac Current Deferred Taxes Liabilities Historical Data

* Premium members only.

The historical data trend for Virbac's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virbac Current Deferred Taxes Liabilities Chart

Virbac Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Virbac Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
VRBCF
80GF Score
Virbac SA VRBCF
Current Deferred Taxes Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Taxes Liabilities of $0 Mil mean?
Virbac (VRBCF) has a Current Deferred Taxes Liabilities of $0 Mil as of Dec. 2025. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Virbac and its competitors.
Is Virbac's Current Deferred Taxes Liabilities too high?
Virbac's current Current Deferred Taxes Liabilities is $0 Mil. Overall, Virbac has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Virbac's Current Deferred Taxes Liabilities compare to LLY and JNJ?
Virbac's Current Deferred Taxes Liabilities of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Taxes Liabilities for a Drug Manufacturers company?
A good Current Deferred Taxes Liabilities depends on the Drug Manufacturers industry context. However, Current Deferred Taxes Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Taxes Liabilities mean?
A high Current Deferred Taxes Liabilities can signal that a stock is expensive relative to its fundamentals. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Virbac and its competitors. Virbac's current Current Deferred Taxes Liabilities is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virbac stock overvalued right now?
Based on GuruFocus' analysis, Virbac (VRBCF) is currently considered Fairly Valued. The stock's GF Value™ is $352.03, compared to a current price of $383.25 — trading 8.9% above its estimated fair value. The current Current Deferred Taxes Liabilities is $0 Mil. Virbac's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Taxes Liabilities calculated?
Current Deferred Taxes Liabilities is calculated from a company's financial statements. For Virbac (VRBCF), the current Current Deferred Taxes Liabilities is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Virbac (VRBCF) Overvalued in 2026?

Based on GuruFocus' analysis, Virbac stock appears to be overvalued. The current stock price of $383.25 is trading 8.9% above its estimated GF Value™ of $352.03. GuruFocus considers Virbac to be Fairly Valued.

Key valuation signals for VRBCF:

  • Current Deferred Taxes Liabilities: $0 Mil
  • GF Value™: $352.03 vs. price of $383.25 (8.9% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the VRBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Virbac Business Description

Address 13e rue, 1ere avenue 2065, LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
80GF Score

Get the complete analysis for VRBCF

Current Deferred Taxes Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$383.25
Price
$352.03
GF Value